Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
NCT01893788
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hypertensive Left Ventricular Hypertrophy
Interventions
DRUG:
Aliskiren
DRUG:
Eplerenone
Sponsor
Nagoya University